Nom du produit:(S)-2-(3,5-Dimethylphenyl)pyrrolidine
IUPAC Name:(2S)-2-(3,5-dimethylphenyl)pyrrolidine
- CAS:1213334-10-1
- Formule moléculaire:C12H17N
- Pureté:95%
- Numéro de catalogue:CM198317
- Poids moléculaire:175.28
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:1213334-10-1
- Formule moléculaire:C12H17N
- Point de fusion:-
- Code SMILES:CC1=CC(C)=CC([C@H]2NCCC2)=C1
- Densité:
- Numéro de catalogue:CM198317
- Poids moléculaire:175.28
- Point d'ébullition:
- N° Mdl:MFCD07772459
- Stockage:Keep in dark place, store at 2-8°C.
Category Infos
- Pyrrolidines
- Pyrrolidine, also known as tetrahydropyrrole, is a saturated five-membered heterocyclic ring, which is miscible with water. Pyrrolidine exists in many alkaloids and drug molecules, such as kappa opioids, antagonists of dopamine D4 receptors, and HIV reverse transcriptase inhibitors.
Column Infos
- Aticaprant
- Major depressive disorder is a leading cause of disability worldwide. Kappa opioid receptors (KORs) are a promising new therapeutic target for major depressive disorder and anhedonia. Aticaprant is a KOR antagonist developed by Johnson & Johnson’s Janssen. Aticaprant is currently being tested as an adjunctive therapy to a current antidepressant in MDD patients with a focus on treating anhedonia. Studies are expected to be completed in mid-to-late 2024 and 2025.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.